Recalls & Warnings November 01, 2017 FDA Warns Sellers of Bodybuilding Supplements Containing Steroid-Like Substances On October 23, 2017, the FDA issued warning letters to three supplement distributors because several of their bodybuilding products contain selective androgen receptor modulators (SARMs)
The time to plan is now As new uses for GLP-1 medications arise, we believe plan sponsors should start preparing now for increased demand and develop a program approach that balances appropriate access with maintaining benefit affordability
Borsani O, Valpuesta V, Botella MA
Many offer telemedicine consultations, expanding access beyond major metropolitan areas
Long-term PPI use carries risks including hypomagnesaemia, vitamin B12 deficiency, and increased fracture risk particularly relevant in bariatric patients already prone to nutritional deficiencies
It is a fine oral mist meant to be sprayed under the tongue or toward the inner cheek